Oneness Biotech Co., Ltd. (4743.TWO) Stock
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
Valuation
Financials & Margins
About Oneness Biotech Co., Ltd.
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation and Organic Food segments. The company offers Fespixon which is a treatment of diabetic foot ulcer; and Bonvadis, a wound care medical device. It also develops FB825, which is in Phase II clinical trial for treating atopic dermatitis and allergic asthma; FB704A which is in Phase II clinical trial for the treatment of rheumatoid arthritis and inhibiting tumor angiogenesis; SNS812, which is in Phase II clinical trial for the treatment of COVID; and SNS851 which is in clinical development for potential applications in metabolic diseases such as obesity, diabetes, hypercholesterolemia, and fatty liver disease. In addition, the company is involved in the management of agriculture cultivation and organic food trading business; and sale of organic food, dietary supplements, and beverages. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.
Oneness Biotech Co., Ltd. is led by CEO Shuling Cheng, employs 180 people, headquartered in Taipei, TW, publicly traded since 2011.
Oneness Biotech Co., Ltd. (4743.TWO) stock trades at $48.15 with a market capitalization of $23.09B. The stock is valued at a price-to-earnings (P/E) ratio of 370.38, price-to-book of 2.25, price-to-sales of 150.13. Over the past 52 weeks the stock has ranged between $40.80 and $76.70, and currently trades 37.2% below its 52-week high.
On profitability, Oneness Biotech Co., Ltd. generates a return on equity (ROE) of 0.62%, an operating margin of -514.87%, a net profit margin of 39.55%.
The balance sheet shows a debt-to-equity ratio of 0.03 (debt below half of shareholders' equity), a current ratio of 37.31.
4743.TWO has an average daily trading volume of 1,498,176 shares, a beta of 0.75 (historically less volatile than the overall market), 0.48B shares outstanding.
Official website: www.onenessbio.com
Oneness Biotech Co., Ltd. (4743.TWO) — frequently asked questions
What is Oneness Biotech Co., Ltd. (4743.TWO) stock price today?
Oneness Biotech Co., Ltd. (4743.TWO) is currently trading at $48.15, down 0.52% today.
What is 4743.TWO P/E ratio?
Oneness Biotech Co., Ltd.'s P/E ratio is 370.38. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 4743.TWO return on equity (ROE)?
Oneness Biotech Co., Ltd.'s return on equity (ROE) is 0.62%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Oneness Biotech Co., Ltd.'s market cap?
Oneness Biotech Co., Ltd. has a market capitalization of $23.09B.
Does 4743.TWO pay a dividend?
Oneness Biotech Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 4743.TWO carry?
Oneness Biotech Co., Ltd. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4743.TWO's profit margin?
Oneness Biotech Co., Ltd. reports a net profit margin of 39.55% — the share of revenue left after every cost, including tax and interest.
What sector is 4743.TWO in?
Oneness Biotech Co., Ltd. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4743.TWO listed on?
Oneness Biotech Co., Ltd. trades on TWO under the ticker 4743.TWO.
What is 4743.TWO's 52-week range?
Over the last year Oneness Biotech Co., Ltd. has traded between $40.80 and $76.70.
Related Healthcare Stocks
Popular Stocks
Screens 4743.TWO currently matches
On the figures above, Oneness Biotech Co., Ltd. passes the filters for 11 of our ready-made screens, among them Low Debt Stocks, High Profit Margin Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.